ask="N/A"
ask_size="N/A"
average_daily_volume="37334"
bid="N/A"
bid_size="N/A"
book_value="0.49"
change="N/A"
change_from_200_day_moving_average="-0.74"
change_from_50_day_moving_average="-0.39"
change_from_52_week_high="-6.09"
change_From_52_week_low="0.44"
change_in_percent="N/A"
close="2.91"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.42"
ebitda="-15.65M"
eps_estimate_current_year="-1.62"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.49"
ex_dividend_date="N/A"
float_shares="4342000"
high="N/A"
high_52_weeks="9.00"
last_trade_date="2/13/2017"
last_trade_price="2.91"
last_trade_size="N/A"
last_trade_time="3:56pm"
low="N/A"
low_52_weeks="2.47"
market_capitalization="24.38M"
moving_average_200_day="3.65"
moving_average_50_day="3.30"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.50"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-20.37%"
percent_change_from_50_day_moving_average="-11.91%"
percent_change_from_52_week_high="-67.67%"
percent_change_from_52_week_low="+17.81%"
previous_close="2.91"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.89"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="2.09"
stock_exchange="NCM"
symbol="VTGN"
volume="0"
weeks_range_52="2.47 - 9.00"
